—
C+
C+ The full Closelook — membership. Open the C+ overview

Apotex Health Corp (APTX.TO) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Apotex Health Corp

APTX.TO in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Apotex Health Corp makes and sells prescription and generic drugs, oncology biosimilars, branded specialty medicines and consumer health products across Canada, the United States, Mexico and India. It runs three lines: conventional generics, specialty generics, and brands and biosimilars, and works with Halo Pharmaceutical under a partnership. It is based in Toronto and sits under SK Artemis Holdings as its parent.
Where it sits in the stack
Apotex Health Corp holds no place in Rubin or Halo, the diary's two build-out indices, so it sits outside the AI stack entirely. It belongs to the wider healthcare sector the diary tracks for context, within drug manufacturing for specialty and generic medicines.
Who it is priced against
Closelook's peer group has not been set for Apotex Health Corp. The comparison the market draws on its own is with Teva Pharmaceutical, another manufacturer of generic and specialty drugs.
Why Closelook tracks it
Apotex Health Corp carries no seat in Rubin or Halo and has no Closelook score built yet. It has not been quoted in any edition of the diary so far.
What the diary watches
Whether the partnership with Halo Pharmaceutical or new biosimilar approvals shift the balance between its generic and specialty lines.

Apotex Health Corp (APTX.TO) trades on the TO exchange in Canada, classified under Healthcare.

The Closelook company score reads 48/100 composite (momentum 63, quality 55, valuation 50) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for APTX.TO, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Drug Manufacturers - Specialty & Generic · 8 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic

Names in the same industry from the Closelook universe; scored names rank on their Closelook score, the rest on trend state.

Compared against APTX.TO on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 0.18%, annual · buybacks 141 m CAD in FY2026

Dividends and capital return

What APTX.TO pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.0600 CAD per share · a 0.18% yield on the 2026-09-17 close 1 distribution, paid once a year 2026-09-17
  • Last distribution 0.0600 CAD per share as the price series records it, within days of the ex-date 2026-09-15
  • By calendar year 2026: 0.0600 CAD to date first distribution recorded in the three-year window: 2026-09-15
  • Dividends paid, FY2026 1.11 bn CAD 9% of earnings
  • Buybacks, FY2026 141 m CAD 1.8% of today's market value
  • Share count +1.4% in FY2026 65 m CAD of stock-based compensation in the year
  • Capital returned 1.25 bn CAD · 272% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Apotex Health Corp (APTX.TO)?

Apotex Health Corp trades as APTX.TO on the TO exchange (Canada) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is APTX.TO in a Closelook index?

Not currently — Apotex Health Corp is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

What is Apotex Health Corp's Closelook composite score?

48 out of 100, with momentum 63, quality 55 and valuation 50 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

What does Apotex Health Corp do?

Apotex Health Corp makes and sells prescription and generic drugs, oncology biosimilars, branded specialty medicines and consumer health products across Canada, the United States, Mexico and India. It runs three lines: conventional generics, specialty generics, and brands and biosimilars, and works with Halo Pharmaceutical under a partnership. It is based in Toronto and sits under SK Artemis Holdings as its parent. Closelook's peer group has not been set for Apotex Health Corp. The comparison the market draws on its own is with Teva Pharmaceutical, another manufacturer of generic and specialty drugs.

Where does Apotex Health Corp sit in the AI build-out?

Apotex Health Corp holds no place in Rubin or Halo, the diary's two build-out indices, so it sits outside the AI stack entirely. It belongs to the wider healthcare sector the diary tracks for context, within drug manufacturing for specialty and generic medicines. Apotex Health Corp carries no seat in Rubin or Halo and has no Closelook score built yet. It has not been quoted in any edition of the diary so far.

Does Apotex Health Corp pay a dividend?

Apotex Health Corp has paid 0.0600 CAD per share over the last twelve months, paid once a year, a trailing yield of 0.18% on the 2026-09-17 close; the last distribution recorded in the price series was 0.0600 CAD on 2026-09-15. In fiscal 2026 the company paid 1.11 bn CAD in dividends and bought back 141 m CAD of its own shares, 272% of that year’s free cash flow. The share count rose 1.4% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for APTX.TO, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.